![]() SNIPR Biome SNIPR Biome is a biotech company using CRISPR/Cas technology for drug development for difficult-to-treat infections. | ![]() Paratek Pharmaceuticals Paratek Pharmaceuticals is focused on the discovery, development, and commercialization of medicines designed to save lives and alleviate suffering. | ![]() Mologic In 2003, two quirky scientists vowed to make the world a better place, after learning their trades in some of the world’s biggest scientific organisations. | ![]() Avidity Biosciences Avidity Biosciences is a biotech company developing oligonucleotide-based therapies called antibody oligonucleotide conjugates (AOC). | ||
Founding Date | Founding Date 2017 | Founding Date 1996 | Founding Date 2003 | Founding Date 2013 | Founding Date 2019 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations København, DK HQ | Locations Boston, US HQ King Of Prussia, US | Locations Thurleigh, GB HQ | Locations San Diego, US HQ | Locations HQ |
Employees | Employees 432% increase | Employees 10123% increase | Employees 652% decrease | Employees 25336% increase | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 127.8 m | Valuation ($) N/A | Valuation ($) 5.3 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $160.3m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $18.8m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($63.6m) (FY, 2022) | Net income N/A | Net income ($684.6m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 50m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 27m (almost 7 years ago) |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 93m | Total funding raised $ 8m | Total funding raised $ 131m | Total funding raised $ 27m |

Paratek Pharmaceuticals is focused on the discovery, development, and commercialization of medicines designed to save lives and alleviate suffering.
View company
In 2003, two quirky scientists vowed to make the world a better place, after learning their trades in some of the world’s biggest scientific organisations.
View company
Avidity Biosciences is a biotech company developing oligonucleotide-based therapies called antibody oligonucleotide conjugates (AOC).
View company